Compare MYO & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MYO | MDBH |
|---|---|---|
| Founded | 2004 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.2M | 35.0M |
| IPO Year | 2017 | 2023 |
| Metric | MYO | MDBH |
|---|---|---|
| Price | $1.01 | $3.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.67 | N/A |
| AVG Volume (30 Days) | ★ 830.5K | 13.9K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.76 |
| Revenue | ★ $41,643,203.00 | $1,250,398.00 |
| Revenue This Year | $24.07 | N/A |
| Revenue Next Year | $17.48 | N/A |
| P/E Ratio | ★ N/A | $4.40 |
| Revenue Growth | ★ 65.00 | N/A |
| 52 Week Low | $0.71 | $3.16 |
| 52 Week High | $7.17 | $7.98 |
| Indicator | MYO | MDBH |
|---|---|---|
| Relative Strength Index (RSI) | 55.62 | 45.95 |
| Support Level | $1.02 | $3.25 |
| Resistance Level | $1.13 | $3.50 |
| Average True Range (ATR) | 0.07 | 0.20 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 59.77 | 28.27 |
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.